Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page
- Check7 days agoChange DetectedThe revision tag on the page was updated from v3.6.5 to v3.6.6, reflecting a software update to the record history interface.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe history shows a new revision entry v3.6.5 added, replacing the previous v3.6.4, indicating a minor update to the record's revision history.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision v3.6.4 was added to the study's history, replacing the previous v3.6.3 and signaling a small update to the record-keeping for this study.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry v3.6.3 was added to the study history, and the previous revision v3.6.2 was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedThe record history shows a new revision tag v3.6.2, replacing v3.6.0. It indicates a page-level update rather than substantive changes to study data.SummaryDifference0.1%

- Check86 days agoChange DetectedRecruitment is closed (no longer looking for participants), indicating enrollment has ended. The history also shows a new page revision to v3.6.0, with the prior v3.5.5 entry removed.SummaryDifference0.5%

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.